Patient Narcoleptic Treated With BF2.649 (Pitolisant) in add-on to Sodium Oxybate (HARMONY IV)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2012
This is a multicentric international phase III, double blind randomized study assessing efficacy and safety in parallel group of BF2.649 (pitolisant) compared to placebo in add-on to sodium oxybate of narcoleptic patients with residual Excessive Daytime Sleepiness (EDS) during 8 weeks
Epistemonikos ID: fa47cdea9fe6d38684156a742194e590e9eafe9e
First added on: May 11, 2024